Fortified extract of red berry, ginkgo biloba, and white willow bark in experimental early diabetic retinopathy

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Bucolo, Claudio ^a   Marrazzo, Giuseppina ^a   Platania, Chiara Bianca Maria ^a   Drago, Filippo ^a   Leggio, Gian Marco ^a   Salomone, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARNOSINE; GINKGO BILOBA EXTRACT; PLANT EXTRACT; RED BERRY EXTRACT; SALIX ALBA EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARK; BERRY; BLOOD ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG ISOLATION; GINKGO BILOBA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RED BERRY; RETINA; STREPTOZOCIN DIABETES; WILLOW; ANIMAL; BACCHARIS; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; LIPID PEROXIDATION; METABOLISM; PHYTOTHERAPY; SPRAGUE DAWLEY RAT; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS;

ANIMALS; BACCHARIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GINKGO BILOBA; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878700816     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/432695     Document Type: Article

References (37)

1. Kowluru R. A., Chan P. S., Oxidative stress and diabetic retinopathy. Experimental Diabesity Research 2007 2007 12 2-s2.0-34247394257 10.1155/2007/43603 43603 (Pubitemid 46630110)
2. Aiello L. P., Northrup J. M., Keyt B. A., Takagi H., Iwamoto M. A., Hypoxic regulation of vascular endothelial growth factor in retinal cells. Archives of Ophthalmology 1995 113 12 1538 1544 2-s2.0-0028826101
3. Limb G. A., Webster L., Soomro H., Janikoun S., Shilling J., Platelet expression of tumour necrosis factor-alpha (TNF- α), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clinical and Experimental Immunology 1999 118 2 213 218 2-s2.0-0032707318 10.1046/j.1365-2249.1999.01067.x (Pubitemid 29519250)
4. Tang J., Kern T. S., Inflammation in diabetic retinopathy. Progress in Retinal and Eye Research 2011 30 5 343 358 2-s2.0-79960190061 10.1016/j.preteyeres.2011.05.002
5. Wu H., Xu G., Liao Y., Supplementation with antioxidants attenuates transient worsening of retinopathy in diabetes caused by acute intensive insulin therapy. Graefe's Archive for Clinical and Experimental Ophthalmology 2012 250 10 1453 1458 10.1007/s00417-012-2079-4
6. Bucolo C., Leggio G. M., Drago F., Salomone S., Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochemical Pharmacology 2012 84 1 88 92 10.1016/j.bcp.2012.03.019
7. Lee S. G., Lee C. G., Yun I. H., Hur D. Y., Yang J. W., Kim H. W., Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina. Clinical & Experimental Ophthalmology 2012 40 1 e47 e57 10.1111/j.1442-9071. 2011.02695.x
8. Pfister F., Riedl E., Wang Q., Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cellular Physiology and Biochemistry 2011 28 1 125 136 10.1159/000331721
9. Packer L., Witt E. H., Tritschler H. J., Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine 1995 19 2 227 250 2-s2.0-0029070687 10.1016/0891-5849(95)00017-R
10. Kojima M., Sun L., Hata I., Sakamoto Y., Sasaki H., Sasaki K., Efficacy of α -lipoic acid against diabetic cataract in rat. Japanese Journal of Ophthalmology 2007 51 1 10 13 2-s2.0-33847148514 10.1007/s10384-006-0384-3 (Pubitemid 46281231)
11. Kyselova Z., Stefek M., Bauer V., Pharmacological prevention of diabetic cataract. Journal of Diabetes and Its Complications 2004 18 2 129 140 2-s2.0-2342443119 10.1016/S1056-8727(03)00009-6 (Pubitemid 38559078)
12. Kowluru R. A., Tang J., Kern T. S., Abnormalities of retinal metabolism in diabetes and experimental galactosemia: VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001 50 8 1938 1942 2-s2.0-0035434119 (Pubitemid 33641616)
13. Kowluru R. A., Odenbach S., Effect of long-term administration of α -lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004 53 12 3233 3238 2-s2.0-9444224415 10.2337/diabetes.53.12.3233 (Pubitemid 39564500)
14. Kowluru R. A., Kanwar M., Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition and Metabolism 2007 4, article no. 8 2-s2.0-34247542013 10.1186/1743-7075-4-8 (Pubitemid 46663082)
15. Kowluru R. A., Kanwar M., Kennedy A., Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Experimental Diabesity Research 2007 2007 7 2-s2.0-34547858127 10.1155/2007/21976 21976 (Pubitemid 47261554)
16. Pacher P., Obrosova I. G., Mabley J. G., Szabó C., Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Current Medicinal Chemistry 2005 12 3 267 275 2-s2.0-14544297961 (Pubitemid 40305619)
17. Jung S. H., Kang K. D., Ji D., Fawcett R. J., Safa R., Kamalden T. A., Osborne N. N., The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes. Neurochemistry International 2008 53 6-8 325 337 2-s2.0-56649103692 10.1016/j.neuint.2008.09. 004
18. Rahman K., Studies on free radicals, antioxidants, and co-factors. Clinical Interventions in Aging 2007 2 2 219 236 2-s2.0-38449121513
19. Marrazzo G., Bosco P., La Delia F., Neuroprotective effect of silibinin in diabetic mice. Neuroscience Letters 2011 504 3 252 256 10.1016/j.neulet.2011. 09.041
20. Nizard C., Noblesse E., Boisdé C., Moreau M., Faussat A. M., Schnebert S., Mahé C., Heat shock protein 47 expression in aged normal human fibroblasts: modulation by Salix alba extract. Annals of the New York Academy of Sciences 2004 1019 223 227 2-s2.0-3242667910 10.1196/annals.1297.037 (Pubitemid 38951310)
21. Gagnier J. J., van Tulder M. W., Berman B., Bombardier C., Herbal medicine for low back pain: a Cochrane review. Spine 1976 32 1 82 92
22. Ilieva I., Ohgami K., Shiratori K., Koyama Y., Yoshida K., Kase S., Kitamei H., Takemoto Y., Yazawa K., Ohno S., The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Experimental Eye Research 2004 79 2 181 187 2-s2.0-4344696660 10.1016/j.exer.2004.03.009 (Pubitemid 39119407)
23. Yoshikawa T., Naito Y., Kondo M., Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxidants and Redox Signaling 1999 1 4 469 480 2-s2.0-0033302430 (Pubitemid 129628310)
24. Bucolo C., Ward K. W., Mazzon E., Cuzzocrea S., Drago F., Protective effects of a coumarin derivative in diabetic rats. Investigative Ophthalmology and Visual Science 2009 50 8 3846 3852 2-s2.0-68349104279 10.1167/iovs.08-3328
25. Faro S., Avitabile T., Malaguarnera G., Effect of an antioxidant blend in diabetic macular edema. Investigative Ophthalmology & Visual Science 2013 54 1968. E-Abstract
26. Ozawa Y., Kurihara T., Sasaki M., Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Experimental Diabetes Research 2011 2011 7 10.1155/2011/108328 108328
27. Amore A., Coppo R., Role of apoptosis in pathogenesis and progression of renal diseases. Nephron 2000 86 2 99 104 2-s2.0-0033815664
28. El-Remessy A. B., Al-Shabrawey M., Khalifa Y., Tsai N. T., Caldwell R. B., Liou G. I., Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. American Journal of Pathology 2006 168 1 235 244 2-s2.0-30344486638 10.2353/ajpath.2006.050500 (Pubitemid 43062576)
29. Joussen A. M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Döhmen S., Adamis A. P., Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 2002 16 3 438 440 2-s2.0-0036517850
30. Vinores S. A., Xiao W. H., Shen J., Campochiaro P. A., TNF- α is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage. Journal of Neuroimmunology 2007 182 1-2 73 79 2-s2.0-33846016638 10.1016/j.jneuroim.2006.09.015 (Pubitemid 46039759)
31. Joussen A. M., Doehmen S., Le M. L., Koizumi K., Radetzky S., Krohne T. U., Poulaki V., Semkova I., Kociok N., TNF- α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Molecular Vision 2009 15 1418 1428 2-s2.0-68149131912
32. Amadio M., Bucolo C., Leggio G. M., Drago F., Govoni S., Pascale A., The PKC β /HuR/VEGF pathway in diabetic retinopathy. Biochemical Pharmacology 2010 80 8 1230 1237 2-s2.0-77956226516 10.1016/j.bcp.2010.06.033
33. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., Inoue I., Katayama S., A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002 51 5 1635 1639 2-s2.0-0036316846 (Pubitemid 34826636)
34. Rangasamy S., McGuire P. G., Das A., Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East African Journal of Ophthalmology 2012 19 52 59
35. Karpen C. W., Pritchard K. A. Jr., Merola A. J., Panganamala R. V., Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats. Prostaglandins and Medicine 1982 8 2 93 103 2-s2.0-0020082406 (Pubitemid 12182389)
36. Armstrong D., Abdella N., Salman A., Miller N., Rahman E. A., Bojancyzk M., Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests. Journal of Diabetes and its Complications 1992 6 2 116 122 2-s2.0-0026969227 10.1016/1056-8727(92)90022-D (Pubitemid 23132711)
37. Hartnett M. E., Stratton R. D., Browne R. W., Rosner B. A., Lanham R. J., Armstrong D., Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000 23 2 234 240 2-s2.0-0033979291 (Pubitemid 30071030)